Evidence map›Paper›PMID 1862089›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1991

Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites.

F V Rassool, T W McKeithan, M E Neilly, E van Melle, R Espinosa, M M Le Beau

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Integration of exogenous DNA into mouse embryonic stem cell chromosomes shows preference into genes and frequent modification at junctions.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2010
    Article
  12. Fhit tumor suppressor: guardian of the preneoplastic genome.Future oncology (London, England) · 2008
    Review
  13. Article
  14. Replication stress induces tumor-like microdeletions in FHIT/FRA3B.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  15. Human papilloma virus DNA exposure and embryo survival is stage-specific.Journal of assisted reproduction and genetics · 2006
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

F V RassoolSection of Hematology/Oncology, University of Chicago, IL 60637.
T W McKeithan
M E Neilly
E van Melle
R Espinosa
M M Le Beau
University of Chicago · US

Funding

MOLECULAR ANALYSIS OF CHROMOSOMAL FRAGILE SITESR01CA041644 · NCI · UNIVERSITY OF CHICAGO · PI LE BEAU, MICHELLE M · 1986 to 2005
$2.1M
CHROMOSOME ABNORMALITIES AND HUMAN LEUKEMIA AND LYMPHOMAR35CA042557 · NCI · UNIVERSITY OF CHICAGO · PI ROWLEY, JANET D · 1986 to 1999
–
NCI NIH HHS CA41644NCI NIH HHS CA42557
6 · The paper itself

Abstract

Fragile sites are specific regions of chromosomes that are prone to breakage. In cells cultured under conditions that induce fragile site expression, high levels of inter- and intrachromosomal recombination have been observed involving chromosomal bands containing fragile sites. To determine whether expression of specific fragile sites would facilitate preferential integration of exogenous DNA at these recombination hot spots, the vector pSV2Neo was transfected into a Chinese hamster-human somatic cell hybrid containing a derivative chromosome 3 as its only human component. Chromosome 3 contains a common fragile site at band 3p14.2 (FRA3B) that is induced by aphidicolin. Both cells induced to express FRA3B and the uninduced control cells were transfected with the pSV2Neo selectable plasmid. In situ hybridization of a biotin-labeled pSV2Neo probe to metaphase chromosomes revealed one to three integration sites in each stably transfected clone. Four of 13 clones transfected under conditions of FRA3B induction showed integration of pSV2Neo at 3p14; these clones also showed specific integration into hamster chromosome 1 and a rearranged chromosome characteristic of CHO cells (mar2). The 7 control clones, however, showed an apparently random pattern of pSV2Neo integration. Significant hybridization of pSV2Neo to both FRA3B and Chinese hamster chromosomes 1 and mar2 was seen in 100 cells from pooled colonies transfected after treatment with aphidicolin. These results suggest that preferential integration of marker DNA into human and Chinese hamster fragile sites occurs with exposure to aphidicolin. The nature of the DNA sequences at fragile sites is unknown and, despite a number of approaches, these sequences have not yet been isolated; our procedure may represent an approach to the cloning of fragile sites.

Indexed as

Chromosome FragilityChromosomes, Human, Pair 3AnimalsChromosome BandingChromosome Fragile SitesChromosome MappingCloning, MolecularDNAFemaleGene RearrangementGenetic MarkersHumansHybrid CellsKaryotypingNucleic Acid HybridizationPlacentaDNAGenetic Markers

Identifiers

PMID1862089
PMCPMC52147
OpenAlexW2008958153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.